Enajat, Morteza <br/><br/>
Safety of the combination of intensive cholesterol-lowering therapy with oral anticoagulation medication in elderly patients with atrial fibrillation: a randomized, double-blind, placebo-controlled study.  [electronic resource] 

 -  Drugs & aging  2009 
 - 585-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-1969 
<br/><br/><label>Standard No.: </label>10.2165/10558450-000000000-00000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Aged, 80 and over<br/>Anti-Inflammatory Agents--administration & dosage<br/>Anticholesteremic Agents--administration & dosage<br/>Anticoagulants--administration & dosage<br/>Atrial Fibrillation--complications<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Interactions<br/>Drug Therapy, Combination<br/>Endpoint Determination<br/>Female<br/>Hemorrhage--etiology<br/>Humans<br/>Male<br/>Medication Adherence<br/>Placebo Effect